1. AIMS (1976). In Guy, W. (ed.), ECDEU Assessment Manual for Psychopharmacology, Department of Health, Education and Welfare, Rockville, Maryland, pp. 534–7.
2. Alba, A., Trainor, F. S., Ritter, W. and Dacso, M. M. (1968). A clinical disability rating for parkinsonian patients. J. Chron. Dis., 21, 507–22.
3. Anden, N. E., Carlsson, A., Kerstell, J., Magnusson, T., Olsson, R., Roose, B. E., Steen, B., Steg, G., Svangorg, A., Thieme, G. and Werdinius, B. (1970). Oral L-dopa treatment of parkinsonism. Acta Med. Scand., 187, 247–55.
4. Barbeau, A., Duvoisin, R. C., Gerstenbrand, F., Lakke, J. P. W. F., Marsden, C. D. and Stern, C. (1981). Classification of extrapyramidal disorders. J. Neurol. Sci., 51, 311–27.
5. Birkmayer, W. and Neumayer, E. (1972). Die moderne medikamentose Behandlung des Parkinsonismus. Z Neurol., 202, 257–64.